Details for Patent: 7,750,029

✉ Email this page to a colleague

Summary for Patent: 7,750,029

Title:	Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Abstract:	(R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]a- cetic acid anilide or its salt shows a potent bladder relaxation effect in "isolated rat bladder smooth muscle relaxation test", dose-dependently lowers the contraction frequency of rhythmic bladder contractions in "rat rhythmic bladder contraction measurement test" and, moreover, prolongs the urination intervals in "urination functions measurement test on cyclophosphamide-induced overactive bladder model rat". Owing to these effects, the above compound is useful as a remedy for ovaractive bladder.
Inventor(s):	Takasu; Toshiyuki (Tsukuba, JP), Sato; Shuichi (Tsukuba, JP), Ukai; Masashi (Tsukuba, JP), Maruyama; Tatsuya (Tsukuba, JP)
Assignee:	Astellas Pharma Inc. (Tokyo, JP)
Application Number:	10/534,290
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,750,029
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,750,029

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,750,029

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2002-323792	Nov 07, 2002

PCT Information
PCT Filed	November 04, 2003	PCT Application Number:	PCT/JP03/14065
PCT Publication Date:	May 21, 2004	PCT Publication Number:	WO2004/041276

International Family Members for US Patent 7,750,029

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1559427	⤷ Sign Up	C300599	Netherlands	⤷ Sign Up
European Patent Office	1559427	⤷ Sign Up	CA 2013 00028	Denmark	⤷ Sign Up
European Patent Office	1559427	⤷ Sign Up	92218	Luxembourg	⤷ Sign Up
European Patent Office	1559427	⤷ Sign Up	13C0032	France	⤷ Sign Up
European Patent Office	1559427	⤷ Sign Up	1390028-7	Sweden	⤷ Sign Up
European Patent Office	1559427	⤷ Sign Up	C20130015 00094	Estonia	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.